Atrium Therapeutics Statistics
NASDAQ: RNAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
8.26+0.33 (+4.16%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 8.24 -0.24%
Atrium Therapeutics by the numbers
Atrium Therapeutics has a market capitalization of $141.3 million based on 17.11M shares outstanding. With trailing EPS of $-5.44, Atrium Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 26.1% below its 50-day average and 34.0% below its 200-day average.
Average daily trading volume is 253.00K shares, or about $2.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RNA valuation vs. peer median
| Metric | RNA | Peer median | Difference |
|---|---|---|---|
| Market cap | $141.29M | $148.77M | -5% |
| Avg. volume | 253.00K | 166.62K | +52% |
Peer median across 8 companies: TLSA, OGI, BGM, SPRB, NERV, VRXA, KRRO, MSLE.
Valuation
- Market cap
- $141.29M
- EPS (TTM)
- $-5.44
- Shares outstanding
- 17.11M
Price and trading
- Previous close
- 7.93
- Open
- 8.15
- Day range
- 7.97 – 8.33
- 52-week range
- 7.63 – 16.77
- Beta
- —
- Volume
- 645.64K
- Average volume
- 253.00K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 141.29M
- Forward Pe
- -1.02
- Eps
- -5.44
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 16.77
- Week52 Low
- 7.63
- Avg Volume
- 253.00K
- Shares Outstanding
- 17.11M
- Ma50
- 11.18
- Ma200
- 12.52
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -50.75%
- Pct From52w Low
- 8.26%